- Home
- BLFS vs ECAT Comparison
BLFS vs ECAT Comparison
Compare BLFS & ECAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLFS | ECAT |
|---|---|---|
| Founded | 1987 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BLFS | ECAT |
|---|---|---|
| Price | $26.01 | $15.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | ★ 734.8K | 503.1K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.20% |
| EPS Growth | ★ 77.27 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $96,214,000.00 | N/A |
| Revenue This Year | $19.73 | N/A |
| Revenue Next Year | $17.82 | N/A |
| P/E Ratio | $1,276.50 | ★ $6.32 |
| Revenue Growth | ★ 16.97 | N/A |
| 52 Week Low | $17.86 | $13.36 |
| 52 Week High | $29.57 | $17.14 |
Technical Indicators
Market Signals| Indicator | BLFS | ECAT |
|---|---|---|
| Relative Strength Index (RSI) | 55.48 | 54.08 |
| Support Level | $23.60 | $15.32 |
| Resistance Level | $26.59 | $15.77 |
| Average True Range (ATR) | 1.41 | 0.25 |
| MACD | -0.24 | -0.04 |
| Stochastic Oscillator | 41.06 | 51.19 |
Price Performance
Historical ComparisonAbout BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
About ECAT BlackRock ESG Capital Allocation Term Trust of Beneficial Interest
BlackRock ESG Capital Allocation Trust is a non-diversified, closed-ended management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation.